FIELD: organic chemistry, medicine, endocrinology. SUBSTANCE: invention concerns an agent used for treatment of insulin resistance, diabetes mellitus, hyperlipidemia and dyslipidemia. Agent comprises bis-(2-hydroxy-N,N, N-trimethylethaneaminium) choline salt succinate. Invention relates also to method for it preparing. EFFECT: valuable medicinal properties and enhanced effectiveness of agent. 4 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF CHOLINE SALT OF SUCCINIC ACID IN PRODUCTION OF AGENTS FOR TREATING CRANIOCEREBRAL INJURY | 2018 |
|
RU2689384C1 |
| 1-DEOXY-1-N-METHYL AMMONIUM-D-GLUCITOLE SUCCINATE | 2007 |
|
RU2345060C1 |
| METHOD FOR TREATMENT OF CEREBRAL ISCHEMIA | 2005 |
|
RU2281765C1 |
| INTRANASAL PHARMACEUTICAL COMPOSITION BASED ON INSULIN | 2016 |
|
RU2619855C1 |
| METHOD FOR INSULIN RESISTANCE CORRECTION IN METABOLIC SYNDROME | 2009 |
|
RU2402326C1 |
| METHOD FOR IMPROVING COGNITIVE FUNCTION | 2005 |
|
RU2281766C1 |
| AGENT FOR METABOLIC SYNDROME CORRECTION | 2011 |
|
RU2458935C1 |
| MODULATION OF THE EXPRESSION OF APOLIPOPROTEIN C-III (APOSIII) IN THE PATIENTS WITH LIPODYSTROPHY | 2016 |
|
RU2737719C2 |
| CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITIONS | 2010 |
|
RU2755902C2 |
| CONCENTRATED THERAPEUTIC PHOSPHOLIPIDE COMPOSITIONS | 2010 |
|
RU2642653C2 |
